* Outset Medical Inc OM.OQ OM.O is expected to show a
fall in
quarterly revenue when it reports results on May 8 for the
period ending December 31 2023
* The San Jose California-based company is expected to
report a
9.3% decrease in revenue to $30.341 million from $33.47 million
a year ago, according to the mean estimate from 7 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Outset Medical Inc is
for a
loss of 55 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Outset
Medical
Inc is $6.00, above its last closing price of $3.79.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.61 -0.61 -0.59 Beat 4.1
Sep. 30 2023 -0.67 -0.67 -0.71 Missed -6.5
Jan. 1 0001 -0.84 -0.76 -0.90 Missed -18
Mar. 31 2023 -0.78 -0.74 -0.90 Missed -21.3
Jan. -0.91 -0.86 -0.86 Met 0
1 0001
Sep. 30 2022 -0.84 -0.81 -0.85 Missed -4.9
Jun. 30 2022 -0.68 -0.70 -0.92 Missed -31.8
Mar. 31 2022 -0.71 -0.72 -0.78 Missed -8.3
This summary was machine generated May 7 at 02:09 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)